Presence of eosinophils in the inflammatory infiltrate of nonsegmental vitiligo: a retrospective study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 19747329)

Published in Clin Exp Dermatol on October 01, 2009

Authors

T S Anbar, H Abdel-Raouf, S S Awad, N H Ragaie, A T Abdel-Rahman

Articles by these authors

Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg (1997) 1.72

An approach to the treatment of severe adult respiratory failure. J Crit Care (1998) 1.44

Extracorporeal life support in pulmonary failure after trauma. J Trauma (1999) 1.25

Use of a Pfannenstiel incision in minimally invasive colorectal cancer surgery is associated with a lower risk of wound complications. Tech Coloproctol (2012) 0.98

Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer. Eur J Surg Oncol (2006) 0.95

Envenoming bites by kraits: the biological basis of treatment-resistant neuromuscular paralysis. Brain (2005) 0.91

A prospective comparison of atrio-femoral and femoro-atrial flow in adult venovenous extracorporeal life support. J Thorac Cardiovasc Surg (1998) 0.91

Effect of rate and inspiratory flow on ventilator-induced lung injury. J Trauma (2000) 0.85

Vitiligo: characterization of melanocytes in repigmented skin after punch grafting. J Eur Acad Dermatol Venereol (2014) 0.84

The hair follicle melanocytes in vitiligo in relation to disease duration. J Eur Acad Dermatol Venereol (2009) 0.84

Use of extracorporeal life support for adult patients with respiratory failure and sepsis. ASAIO J (1998) 0.82

Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites. Photodermatol Photoimmunol Photomed (2006) 0.80

Vitiligo occurring at site of interferon-alpha 2b injection in a patient with chronic viral hepatitis C: a case report. Clin Exp Dermatol (2008) 0.79

The role of radiotherapy in treating small early invasive breast cancer. Eur J Surg Oncol (2007) 0.77

Leflunomide is a possible deactivator for vitiligo, a pilot study. J Eur Acad Dermatol Venereol (2011) 0.75

Perifollicular inflammatory infiltrate in vitiligo. Int J Dermatol (2011) 0.75